---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253143938.md"
description: "JINGXIN: As of the announcement date, a total of 290 million yuan of the raised funds for temporarily supplementing working capital has been fully returned to the special account for raised funds, and the usage period has not exceeded 12 months"
datetime: "2025-08-15T03:59:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253143938.md)
  - [en](https://longbridge.com/en/news/253143938.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253143938.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/253143938.md) | [繁體中文](https://longbridge.com/zh-HK/news/253143938.md)


# 

JINGXIN: As of the announcement date, a total of 290 million yuan of the raised funds for temporarily supplementing working capital has been fully returned to the special account for raised funds, and the usage period has not exceeded 12 months

### Related Stocks

- [JINGXIN (002020.CN)](https://longbridge.com/en/quote/002020.CN.md)

## Related News & Research

- [Nvidia powers further into the CPU market with new rack systems packing 256 Vera processors](https://longbridge.com/en/news/279313591.md)
- [At Nvidia GTC 2026, Samsung Electronics Showcases Nvidia's Next-Generation AI Inference Processor Manufactured Using Samsung's 4nm Foundry Process](https://longbridge.com/en/news/279331502.md)
- [Trump to hold news conference Monday prior to Kennedy Center board meeting](https://longbridge.com/en/news/279284985.md)
- [Nvidia announces Vera Rubin Space-1 chip system for orbital AI data centers](https://longbridge.com/en/news/279319883.md)
- [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/en/news/279032574.md)